Compositions and methods for modifying toxic effects of proteinaceous compounds

Details for Australian Patent Application No. 2003295364 (hide)

Owner Board of Regents, The University of Texas System

Inventors Ghetie, Victor, F.; Baluna, Roxana G.; Vitetta, Ellen S.; Smallshaw, Joan

Agent Pizzeys

Pub. Number AU-B-2003295364

PCT Number PCT/US2003/0344

PCT Pub. Number WO2004/040262

Priority 10/282,935 29.10.02 US

Filing date 29 October 2003

Wipo publication date 25 May 2004

Acceptance publication date 2 April 2009

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 14/55 (2006.01) Peptides having more than 20 amino acids

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 19/00 (2006.01) Hybrid peptides

Event Publications

22 April 2004 Complete Application Filed

  Priority application(s): 10/282,935 29.10.02 US

24 June 2004 Application Open to Public Inspection

  Published as AU-B-2003295364

2 April 2009 Application Accepted

  Published as AU-B-2003295364

30 July 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003295365-Dunnage converter system, components and method

2003295363-LNG PROCESS WITH IMROVED METHANE CYCLE